VKTX stock gains support from September conference dates

Viking Therapeutics (VKTX) stock ended September 2, 2026 at USD 33.50, with a market value of USD 3.91 billion and 1.57 million shares traded. The company said on September 2, 2026 that it will present at three health-care conferences in September.

September brings the next dates

According to a company release reported by Benzinga, Viking will take part in the Cantor Global Healthcare Conference from September 9-11, 2026, the Morgan Stanley Global Healthcare Conference from September 14-16, 2026 and the Bernstein Healthcare Forum on September 23-24, 2026. The Morgan Stanley webcast is scheduled for September 14, 2026 at 3:20 pm ET.

That makes the September calendar the key near-term catalyst for a stock that has already risen 21.86 percent over the last 12 months and 5.55 percent in the past month.

Trading stays firm

MarketBeat shows VKTX closing at USD 33.50 on September 2, 2026, after a session range of USD 32.77 to USD 34.75 and a year-to-date return of minus 4.78 percent. The share price sits below the 12-month gain but remains above the August 28, 2026 close of USD 32.16.

For chart watchers, the stock recovered 4.17 percent over the last five days and traded with a market cap near USD 3.91 billion as of September 2, 2026. The latest close also came after a one-day gain of 2.72 percent on September 1, 2026 from USD 32.78 to USD 33.67.

VK2735 remains central

The main product story still revolves around VK2735, Viking's dual GLP-1 and GIP receptor agonist in development for obesity in both subcutaneous and oral forms. The company also lists VK3019, VK2809 and VK0214 as additional programs in its pipeline.

Those programs matter because the conference sequence gives management another venue to discuss pipeline progress and clinical milestones in public. The company description in the September 2, 2026 release still frames Viking as a clinical-stage biopharmaceutical group focused on metabolic and endocrine disorders.

Market value at a glance

As of September 2, 2026, VKTX traded at USD 33.50, with an extended-hours quote of USD 33.52 at 7:54 pm Eastern on MarketBeat. The stock's 52-week range was not stated in the available market snapshot, but the close leaves the shares well above the USD 7.04 level seen five years ago.